Cilostazol Uses
Links shared publicly online about this topic
Cilostazol could cut repeat stroke rate | Healthcare Republic
healthcarerepublic.com — “Cilostazol could cut repeat stroke rate | Healthcare Republic” View full resource at healthcarerepublic.com
Most Recently Shared on September 13, 2010 at 1:25 pm By:
Cilostazol could cut repeat stroke rate: Using cilostazol, rather than aspirin, to prevent repeat stroke is associ... http://bit.ly/csZ8th
Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
hindawi.com — “Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also the use of clopidogrel is not without side effects. Clopidogrel major adverse events are represented by marrow suppression, manifesting with aplastic anaemia, thrombocytopenia and neutropenia. When clopidogrel toxicity occurs, there are few and ” View full resource at hindawi.com
Most Recently Shared on August 11, 2011 at 5:48 pm By:
Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?: We report a case of ... http://bit.ly/qZmVOm
Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events : The Lancet Neurology
thelancet.com — “Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. By - Graeme J Hankey FRACP, John W Eikelboom FRACP” View full resource at thelancet.com
Most Recently Shared on February 26, 2010 at 12:19 am By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Antithrombotic drugs to treat TIA and ischemic stroke - http://bit.ly/cmBc6n
Medical News: ASA: Antiplatelet Tops Aspirin for Secondary Stroke Prevention - in Meeting Coverage, ASA from MedPage Today
medpagetoday.com — “Cilostazol, an antiplatelet agent used in the U.S. to treat intermittent claudication, was better than aspirin at preventing recurrent stroke from noncardiogenic sources, a randomized trial conducted” View full resource at medpagetoday.com
Most Recently Shared on February 26, 2010 at 9:07 pm By:
ASA: Antiplatelet Tops Aspirin for Secondary Stroke Prevention (CME/CE) Cilostazol, an antiplatelet agent used in the.. http://bit.ly/9I8oWJ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Stroke OW
Organizing stroke and mini-stroke resources shared by health experts, advocates, and organizations into WisdomCards.
-
Toxins OW
Organizing toxins and chemicals resources shared by health experts, advocates, and organizations into WisdomCards.
-
M Auron MD
Internist and Pediatrician. Hospitalist.
Advertisement
